|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.00 GBX | 0.00% |
|
+0.35% | +11.72% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 2.95x | - | 2.41x | 10.95x | 35.43x | -.--% | 162M | |
| -173.05x | 11.49x | 0.59x | 25.43x | 61.07x | -108.13x | -.--% | 71.93B | |
| 38.52x | 4.19x | 0.5x | 2.95x | 23.35x | 37.49x | 1.14% | 4.31B | |
| 106.81x | 6.47x | 1.89x | 13.37x | 19.5x | 116.93x | 0.29% | 3.38B | |
| 42.17x | 15.71x | 59.98x | 12.9x | 28.82x | 33.4x | 1.66% | 2.12B | |
| -26.31x | 3.8x | 0.46x | - | - | - | 0.1% | 1.29B | |
| 41.14x | 8.33x | 1.29x | 16.97x | 26.33x | 28.9x | 0.56% | 1.22B | |
| 15.38x | 4.54x | 0.39x | - | - | - | 0.38% | 1.15B | |
| 24.95x | 2.17x | 32.05x | 3.9x | 14.05x | 17.35x | 0.66% | 1.14B | |
| -1.87x | - | 0.24x | 5.09x | 8.32x | 96.15x | -.--% | 507M | |
| 26.86x | 3.17x | 2.96x | 2.75x | 8.41x | 13.81x | - | 164M | |
| -56.94x | 4.64x | 0.64x | 1.54x | 11.89x | -39.03x | - | 127M | |
| 27.11x | 6.1x | -1.41x | 1.1x | 12.83x | 16.46x | -.--% | 75.19M | |
| Average | 5.40x | 6.13x | 8.30x | 8.04x | 20.50x | 22.61x | 0.43% | 6.74B | |
| Weighted average by Cap. | -134.64x | 10.62x | 2.50x | 22.83x | 54.96x | -82.72x | 0.13% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
